knowledge -WSS

knowledge

author：focus 2025-10-01 22:48:26 - browse：55

Christoph Lengauer stands for a portrait. -- biotech coverage from STAT — Christoph Lengauer, co-founder and CSO of Curie.Bio Vanessa Leroy for STAT

Curie.Bio, the new biotech investment firm and incubator launched earlier this year by a group of industry veterans including Alexis Borisy and Zach Weinberg, has graduated its first startup.

The startup, Forward Therapeutics, is coming out of the incubator with three drug candidates for chronic inflammatory disorders. It also just closed its first major financing round: a $50 million Series A round led by BVF Partners, with participation from RA Capital Management and OrbiMed. That money should be enough for Forward to begin clinical trials — a rare feat in the biotech world, where companies often need to raise multiple private financing rounds in order to be ready for human tests.

“Usually, with Series A money, you get a development candidate, and use Series B to take molecules to the clinic,” Forward CEO Toufike Kanouni told STAT. But with the Curie team’s help, and the $8 million in seed financing it provided, Forward was able to move much faster.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Future doctors need a strong humanities education

WSS

What’s missing from the debate over nursing home staff minimums

340B reform proposal comes out of Senate working group

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Immunocompromised patients offer clues on chronic Covid

Why Novartis is going to walk from its acquisition of MorphoSys

Cardiologists urge adding sexual orientation, gender identity to health records

explore

knowledge

focus

23andMe had bad news about my health. I wish a person had delivered it

A single Democrat is willing to weaken Medicare negotiation power

Bright Health sells Medicare Advantage business to Molina

Adopting new red light myopia treatments may be short

Medical records are filled with copy

What causes osteoarthritis? Researchers study link to brain protein

DIEP, the 'gold standard' of breast reconstruction, is under threat

Devoted Health’s losses in Medicare Advantage persist

Hollywood unions extend contract negotiations for actors

The CDC's new social media misinformation war

focus

AstraZeneca stays mum on Medicare drug pricing negotiations

340B reform proposal comes out of Senate working group

Medicare Advantage plans can’t deny care with AI, CMS warns

Update the Apgar Score to remove skin color

Top private equity targets in 2023: cardiology, clinical trials, lasers

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

focus

knowledge

leisure time

leisure time